Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers (IRAM)

NCT03323424 is registered in ClinicalTrials.gov with Institut de Cancérologie de la Loire as lead sponsor.

NCT NCT03323424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03323424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers (IRAM)
Lead sponsor
Institut de Cancérologie de la Loire
Phase
Phase 2
Overall status
Withdrawn
Start date
January 1, 2019
Completion date
February 1, 2026
Enrollment
0 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic breast cancer, metastatic colorectal cancer, metastatic head and neck cancer